Jeffrey L. Cummings

12.8k total citations · 3 hit papers
53 papers, 5.8k citations indexed

About

Jeffrey L. Cummings is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Neurology. According to data from OpenAlex, Jeffrey L. Cummings has authored 53 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Psychiatry and Mental health, 14 papers in Cognitive Neuroscience and 13 papers in Neurology. Recurrent topics in Jeffrey L. Cummings's work include Dementia and Cognitive Impairment Research (17 papers), Alzheimer's disease research and treatments (9 papers) and Neurological disorders and treatments (8 papers). Jeffrey L. Cummings is often cited by papers focused on Dementia and Cognitive Impairment Research (17 papers), Alzheimer's disease research and treatments (9 papers) and Neurological disorders and treatments (8 papers). Jeffrey L. Cummings collaborates with scholars based in United States, United Kingdom and Netherlands. Jeffrey L. Cummings's co-authors include Michael S. Mega, Jeffrey Gornbein, Jan Larsen, Dag Aarsland, Knut Laake, Julia Chung, Nan-Young Lim, Carmen Janvin, Bruce L. Miller and Susan O’Connor and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and American Journal of Psychiatry.

In The Last Decade

Jeffrey L. Cummings

53 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The spectrum of behavioral changes in Alzheimer's disease

1996 871 citations Michael S. Mega, Jeffrey L. Cummings et al. Neurology profile →
Depression and Parkinson's disease: a review

1992 827 citations Jeffrey L. Cummings profile →
Donanemab: Appropriate use recommendations

2025 39 citations D. J. Selkoe, Suzanne E. Schindler et al. The Journal of Prevention of Alzheimer s Disease profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey L. Cummings United States	34	2.4k	2.1k	1.2k	1.1k	796	53	5.8k
Daniel Kaufer United States	42	4.2k 1.8×	1.7k 0.8×	1.3k 1.0×	2.0k 1.8×	593 0.7×	102	7.4k
Stanley Berent United States	44	3.2k 1.4×	1.2k 0.6×	1.9k 1.6×	1.3k 1.2×	1.4k 1.8×	114	7.8k
Sibel Tekin United States	21	1.7k 0.7×	1.4k 0.7×	1.1k 0.9×	889 0.8×	469 0.6×	35	3.8k
Francesco Monaco Italy	39	2.8k 1.2×	965 0.5×	734 0.6×	705 0.6×	786 1.0×	170	6.4k
Nobutsugu Hirono Japan	41	2.9k 1.2×	1.0k 0.5×	1.5k 1.2×	1.8k 1.6×	553 0.7×	101	5.1k
Tiffany W. Chow Canada	37	1.8k 0.8×	1.1k 0.5×	1.1k 0.9×	1.4k 1.3×	363 0.5×	95	4.3k
Erich Mohr Canada	30	1.4k 0.6×	924 0.4×	1.2k 1.0×	524 0.5×	684 0.9×	80	4.1k
Karen L. Bell United States	39	3.7k 1.6×	860 0.4×	1.3k 1.0×	2.6k 2.4×	672 0.8×	71	7.0k
Susan Rosenberg-Thompson United States	11	4.6k 2.0×	1.0k 0.5×	1.7k 1.4×	1.5k 1.4×	250 0.3×	13	6.9k
Po H. Lu United States	45	2.2k 0.9×	681 0.3×	1.7k 1.4×	1.2k 1.1×	605 0.8×	78	6.3k

Countries citing papers authored by Jeffrey L. Cummings

Since Specialization

Citations

This map shows the geographic impact of Jeffrey L. Cummings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey L. Cummings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey L. Cummings more than expected).

Fields of papers citing papers by Jeffrey L. Cummings

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey L. Cummings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey L. Cummings. The network helps show where Jeffrey L. Cummings may publish in the future.

Co-authorship network of co-authors of Jeffrey L. Cummings

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey L. Cummings. A scholar is included among the top collaborators of Jeffrey L. Cummings based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey L. Cummings. Jeffrey L. Cummings is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sikosek, Tobias, Joanna Mika, Mustafa Kahraman, et al.. (2025). Early detection of Alzheimer’s disease using small RNAs. Results from the EPAD cohort. The Journal of Prevention of Alzheimer s Disease. 12(8). 100257–100257. 1 indexed citations

Joie, Renaud La, Jeffrey L. Cummings, Jeffrey L. Dage, et al.. (2025). Treatment‐related amyloid clearance (TRAC): a framework to characterize patients in the era of anti‐amyloid therapies. Alzheimer s & Dementia. 21(11). e70997–e70997. 2 indexed citations

Selkoe, D. J., Suzanne E. Schindler, Paul Aisen, et al.. (2025). Donanemab: Appropriate use recommendations. The Journal of Prevention of Alzheimer s Disease. 12(5). 100150–100150. 39 indexed citations breakdown →

Abushakra, Susan, Anton P. Porsteinsson, Philip Scheltens, et al.. (2017). CLINICAL EFFECTS OF TRAMIPROSATE IN APOE4/4 HOMOZYGOUS PATIENTS WITH MILD ALZHEIMER’S DISEASE SUGGEST DISEASE MODIFICATION POTENTIAL. The Journal of Prevention of Alzheimer s Disease. 4(3). 1–8. 61 indexed citations

Abushakra, Susan, Anton P. Porsteinsson, B. Vellas, et al.. (2016). CLINICAL BENEFITS OF TRAMIPROSATE IN ALZHEIMER’S DISEASE ARE ASSOCIATED WITH HIGHER NUMBER OF APOE4 ALLELES: THE “APOE4 GENE-DOSE EFFECT”. The Journal of Prevention of Alzheimer s Disease. 3(4). 1–10. 50 indexed citations

Chung, Julia & Jeffrey L. Cummings. (2000). NEUROBEHAVIORAL AND NEUROPSYCHIATRIC SYMPTOMS IN ALZHEIMER'S DISEASE. Neurologic Clinics. 18(4). 829–846. 132 indexed citations

Bartzokis, George, Jeffrey L. Cummings, Charles H. Markham, et al.. (1999). MRI evaluation of brain iron in earlier- and later-onset Parkinson’s disease and normal subjects. Magnetic Resonance Imaging. 17(2). 213–222. 179 indexed citations

Litvan, Irene, Jeffrey L. Cummings, & Michael S. Mega. (1998). Neuropsychiatric features of corticobasal degeneration. Journal of Neurology Neurosurgery & Psychiatry. 65(5). 717–721. 110 indexed citations

Binetti, Giuliano, Michael S. Mega, Eugenio Magni, et al.. (1998). Behavioral Disorders in Alzheimer Disease: A Transcultural Perspective. Archives of Neurology. 55(4). 539–539. 89 indexed citations

10.

Mendez, Mario F., et al.. (1996). Frontotemporal dementia versus Alzheimer's disease. Neurology. 47(5). 1189–1194. 78 indexed citations

11.

Cummings, Jeffrey L., et al.. (1996). Schizophrenia and Alzheimer's disease: Clinical and pathophysiologic analogies. Comprehensive Psychiatry. 37(3). 188–195. 72 indexed citations

12.

Jenike, Michael A., Scott L. Rauch, Jeffrey L. Cummings, Cary R. Savage, & Wayne K. Goodman. (1996). Recent Developments in Neurobiology of Obsessive-Compulsive Disorder. The Journal of Clinical Psychiatry. 57(10). 492–503. 15 indexed citations

13.

Cummings, Jeffrey L.. (1995). Lewy Body Diseases with Dementia - Pathophysiology and Treatment. Brain and Cognition. 28(3). 266–280. 14 indexed citations

14.

Cummings, Jeffrey L., et al.. (1992). Obsessive-compulsive disorder in Huntington's disease. Biological Psychiatry. 31(3). 263–270. 126 indexed citations

15.

Mahler, Michael E. & Jeffrey L. Cummings. (1991). Behavioral Neurology of Multi-Infarct Dementia. Alzheimer Disease & Associated Disorders. 5(2). 122–130. 18 indexed citations

16.

Dian, Larry, et al.. (1990). Personality Alterations in Multi-Infarct Dementia. Psychosomatics. 31(4). 415–419. 11 indexed citations

17.

Friedlander, Arthur H., Mark Mills, & Jeffrey L. Cummings. (1988). Consent for dental therapy in severely ill patients. Oral Surgery Oral Medicine Oral Pathology. 65(2). 179–182. 8 indexed citations

18.

Cummings, Jeffrey L.. (1988). Depression in vascular dementia.. PubMed. 10(2). 209–31. 13 indexed citations

19.

Cummings, Jeffrey L., et al.. (1988). Personality Alterations in Dementia of the Alzheimer Type. Archives of Neurology. 45(11). 1187–1190. 105 indexed citations

20.

Cummings, Jeffrey L.. (1986). Subcortical Dementia Neuropsychology, Neuropsychiatry, and Pathophysiology. The British Journal of Psychiatry. 149(6). 682–697. 230 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact